{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:15:21Z","timestamp":1672848921864},"reference-count":32,"publisher":"American Society of Consultant Pharmacists","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:p><jats:bold>Patient History<\/jats:bold> A 67-year-old male presented with symptoms of mania eight days after switching from sertraline to bupropion. His past medical history included benign prostatic hyperplasia, erectile dysfunction, insomnia, and a recent diagnosis of depression. He denied previous\n history of depression but reported taking sertraline for premature ejaculation, an off-label use. His baseline aspartate aminotransferase (AST) was 20 U\/L and alanine transaminase (ALT) was 22 U\/L. Bupropion was held on admission and olanzapine 5 mg nightly was initiated to treat mania. Following\n six days of olanzapine treatment, his liver function tests (LFTs) were elevated (AST = 83 U\/L, ALT = 105 U\/L) and peaked two days later at AST being 2,024 U\/L and ALT being 1,508 U\/L. Other causes of LFT elevation were ruled out since no other new medications were started and the patient denied\n use of acetaminophen. Olanzapine was subsequently discontinued and his LFTs began to improve. His symptoms of mania resolved, and he was discharged on no psychotropic medications.  <jats:bold>Review of Literature<\/jats:bold> A literature search identified 6 cases of bupropion-induced mania\/hypomania\n and 10 cases of olanzapine-induced increased LFTs. This case will add to the limited reports regarding these adverse effects.  <jats:bold>Conclusion<\/jats:bold> Possible adverse drug reactions (ADRs) were observed between the initiation of bupropion and the development of manic symptoms as well\n as the initiation of olanzapine and elevated LFTs. The case report also focuses on the role of pharmacy in a patient with multiple ADRs from psychotropic medications and the importance of gaining collateral information and clarifying indications of prescribed medications.<\/jats:p>","DOI":"10.4140\/tcp.n.2022.399","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T04:34:49Z","timestamp":1661834089000},"page":"399-411","source":"Crossref","is-referenced-by-count":2,"title":["Olanzapine-Induced Elevated Liver Function Tests in an Older Person Treated for Antidepressant-Induced Mania"],"prefix":"10.4140","volume":"37","author":[{"given":"N. Kierstin","family":"Reid","sequence":"first","affiliation":[{"name":"1 PGY2 Critical Care Pharmacy Resident, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eram","family":"Alam","sequence":"additional","affiliation":[{"name":"2 Virginia Commonwealth University School of Pharmacy, Richmond, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Moke","sequence":"additional","affiliation":[{"name":"3 Remedi Senior Care, Richmond, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Woessner","sequence":"additional","affiliation":[{"name":"4 Bon Secours Richmond Community Hospital, Richmond, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ericka L.","family":"Crouse","sequence":"additional","affiliation":[{"name":"2 Virginia Commonwealth University School of Pharmacy, Richmond, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","reference":[{"key":"ref1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders,","year":"2013"},{"key":"ref2","volume-title":"LiverTox: Clinical and Research information on drug-induced liver injury.","year":"2019"},{"issue":"1","key":"ref3","first-page":"1","article-title":"A case of hypomania during nicotine cessation treatment with bupropion.","volume":"8","year":"2013","journal-title":"Addict Sci Clin Pract."},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1345\/aph.19313","article-title":"Mania with bupropion: a dose-related phenomenon?","volume":"34","year":"2000","journal-title":"Ann Pharmacother."},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1176\/jnp.23.2.jnpe51","article-title":"Bupropion-induced mania and hypomania: a report of two cases.","volume":"23","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci."},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.9740\/mhc.2016.11.314","article-title":"Mania possibly linked with bupropion for smoking cessation: a case report.","volume":"6","year":"2016","journal-title":"Ment Health Clin."},{"issue":"8","key":"ref7","first-page":"746","article-title":"Bupropion-induced hypomania in a patient with unipolar depression.","volume":"42","year":"2008","journal-title":"Aust N Z J Psych."},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4140\/TCP.n.2021.68","article-title":"Medication related problems.","volume":"36","year":"2021","journal-title":"Sr Care Pharm."},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4088\/JCP.v65n0716","article-title":"Antidepressant-withdrawal mania: a critical review and synthesis of the literature.","volume":"65","year":"2004","journal-title":"J Clin Psychiatry."},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/gps.3894","article-title":"Mania during antidepressant withdrawal in late-onset depression.","volume":"28","year":"2013","journal-title":"Int J Geriatr Psychiatry."},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0976-500X.171878","article-title":"Mirtazapine withdrawal-induced mania.","volume":"6","year":"2015","journal-title":"J Pharmacol Pharmacother."},{"issue":"1","key":"ref12","first-page":"47","article-title":"Antipsychotic drugs and liver injury.","volume":"30","year":"2018","journal-title":"Shanghai Arch Psychiatry."},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1097\/MJT.0000000000000615","article-title":"Psychotropic drugs and liver toxicity.","volume":"25","year":"2018","journal-title":"Am J Ther."},{"issue":"5","key":"ref14","first-page":"394","article-title":"Possible olanzapine-induced hepatotoxicity in a young Chinese patient.","volume":"15","year":"2009","journal-title":"Hong Kong Med J."},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-138-4-200302180-00024","article-title":"Acute hepatocellular-cholestatic liver injury after olanzapine therapy.","volume":"138","year":"2003","journal-title":"Ann Intern Med."},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/cap.2016.0178","article-title":"Management of hepatotoxicity induced by the use of olanzapine.","volume":"27","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13651500410005577","article-title":"Hepatotoxicity, leucopenia and neutropenia associated with olanzapine therapy.","volume":"8","year":"2004","journal-title":"Int J Psychiatry Clin Pract."},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.pnpbp.2009.09.011","article-title":"Late-onset cholestatic hepatitis induced by olanzapine in a patient with schizophrenia.","volume":"33","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4321\/S1130-01082012001100017","article-title":"Liver toxicity due to olanzapine.","volume":"104","year":"2012","journal-title":"Rev Esp Enferm Dig."},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.pnpbp.2006.03.014","article-title":"Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity.","volume":"30","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.pra.0000452568.92449.3f","article-title":"Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.","volume":"20","year":"2014","journal-title":"J Psychiatric Pract."},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000441-200102000-00008","article-title":"A case report of olanzapine-induced hypersensitivity syndrome.","volume":"321","year":"2001","journal-title":"Am J Med Sci."},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","article-title":"Psychotropic drugs and liver disease: a critical review of pharmacokinetics and liver toxicity.","volume":"8","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther."},{"issue":"2","key":"ref24","first-page":"99","article-title":"Interactions between cytochrome P450 system and the second-generation antipsychotics.","volume":"28","year":"2003","journal-title":"J Psychiatry Neurosci."},{"key":"ref25","journal-title":"Label: Olanzapine and Fluoxetine Combination Prescribing Information."},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4140\/TCP.n.2013.584","article-title":"Tamoxifen and depression: drug interactions in breast cancer.","volume":"28","year":"2013","journal-title":"Consult Pharm."},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.","volume":"16","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pbb.2013.11.003","article-title":"Antidepressant-induced sexual dysfunction in men.","volume":"121","year":"2014","journal-title":"Pharmacol Biochem Behav."},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14656566.2018.1494725","article-title":"Drug treatment options for premature ejaculation.","volume":"19","year":"2018","journal-title":"EXP Opin Pharmacother."},{"issue":"11","key":"ref30","first-page":"102","article-title":"Premature ejaculation: aetiology and treatment strategies.","volume":"7","year":"2019","journal-title":"Med Sci (Basel)."},{"issue":"23","key":"ref31","doi-asserted-by":"crossref","first-page":"e15989","DOI":"10.1097\/MD.0000000000015989","article-title":"Efficacy and safety of sertraline for the treatment of premature ejaculation: systematic review and meta-analysis.","volume":"98","year":"2019","journal-title":"Medicine (Baltimore)."},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/iju.13202","article-title":"Current and emerging therapies in premature ejaculation: where we are coming from, where we are going.","volume":"24","year":"2017","journal-title":"Int J Urol."}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2022\/00000037\/00000009\/art00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T04:33:23Z","timestamp":1662006803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2022.399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,1]]}},"alternative-id":["2639-9636(20220901)37:9L.399;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2022.399","relation":{},"ISSN":["2639-9636"],"issn-type":[{"value":"2639-9636","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}